Obesity Research: Part I Donna Ryan, M.D., James Hill, Ph.D., Fred Turek, Ph.D., et al Discuss the evidence for weight loss and lifestyle interventions in the context of obesity management and cardiometabolic risk. Counsel patients about sleep and its relationship to obesity and metabolic dysregulation. Explain the concept of gene-environment interaction in the context of obesity. Identify patients at increased risk for nonalcoholic fatty liver disease (NAFLD). Diagnose and manage NAFLD.CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™
Obesity Research: Part II Christopher Newgard, Ph.D., Steven Smith, M.D., Susan Phillips, M.D., et al Summarize the findings of metabolomic research in type 2 diabetes and discuss the potential therapeutic implications. Discuss the role of peptide hormones in satiety and their potential use for weight loss. Detail the actions of adiponectin and describe its relationship to adiposity. Theorize about the relation of brain response to fat intake and adiposity. Estimate the disposition index and apply it to clinical practice. CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™
Bariatric Surgery: Issues to Consider Before and After Ken Fujioka, M.D., Walter J. Pories, M.D., Francesco Rubino, M.D., et al Identify potential candidates for bariatric surgery. Counsel patients who are considering bariatric surgery for weight loss and/or management of obesity-associated comorbidities. Compare the safety and efficacy profiles of the most common bariatric procedures. Describe the sleeve gastrectomy and compare it to more established bariatric procedures. Evaluate patients who are regaining weight after bariatric surgery and refer accordingly.CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™
Barriers to Diabetes and Weight Management Amy Ozier, Ph.D., R.D. Teresa Reyes, Ph.D., Jane Reusch, M.D., et al Identify patients with maladaptive eating behaviors and refer them for appropriate interventions or support. Compare the neural responses to food and drugs of abuse with regard to activation of the reward circuitry of the brain. Describe the effects of diabetes on functional exercise capacity. Improve patient education by implementing principles of clear communication. Advocate for improved access to healthy options related to diet and physical activity.CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™
Diabetes: Getting to the Heart of the Matter Eberhard Standl, M.D., Iskandar Idris, M.D., Joost van Melle, M.D., Ph.D., et al Explore and quantitate the diabetic condition as a cardiovascular (CV) risk equivalent. Enhance clinical understanding of how diabetic pathophysiology shapes CV risk. Evaluate the role of diabetic cardiomyopathy in the development of fibrosis as a risk factor for acute coronary events. Identify the importance of foot examinations for screening for peripheral arterial disease to mitigate CV mortality risk. Optimize management of risk factors by prioritizing interventions according to magnitude of effect in individual patients.CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™
Medical Management: Glucose and Lipids Vivian Fonseca, M.D., M. Sue Kirkman, M.D., Matthew Riddle, M.D., et al Initiate and adjust combination therapy to achieve glycemic control in patients with type 2 diabetes. Select oral agents to improve glycemic control in patients taking basal insulin. Work with patients to establish and meet therapeutic goals to reduce cardiovascular risk. Target low-density lipoprotein cholesterol levels to reduce cardiovascular risk in patients with diabetes. Implement a population approach to identify care gaps and improve diabetes management. CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™
Insulin and Insulin Resistance Gerald Reaven, M.D., Philipp Scherer, Ph.D., George Grunberger, M.D., et al Identify patients with insulin resistance by using surrogate markers. Describe the process of fat expansion and its relation to inflammation. Counsel patients about obesity, diabetes, and increased risk for cardiovascular disease, cancer, and other adverse outcomes. Summarize the effects of insulin resistance and hyperinsulinemia on the major organ systems. Risk-stratify patients with respect to cardiovascular risk based on obesity, ethnicity, presence of insulin resistance, and other cardiometabolic risk factors. CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™
Diabetes Management and Models of Chronic Care Thomas Rosenthal, M.D., Susan Cornell, Pharm.D., C.D.E., Mary Ann Hodorowicz, R.D., C.D.E., C.E.C., M.B.A., et al Provide comprehensive management and support services by applying aspects of the patient-centered medical home model. Design and implement a program for shared medical appointments for diabetes management and education. Manage the transition from pediatric to adult care of patients with diabetes. Utilize information technology to improve patient care and outcomes. CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™
2011 Management Update David Kendall, M.D., Carol Wysham, M.D., Jack Leahy, M.D., et al Individualize management targets to decrease cardiometabolic risk in patients with diabetes. Select appropriate patients for incretin-based therapy. Manage hyperglycemia in hospitalized patients. Identify patients at risk for severe hypoglycemia and mitigate risk through management strategies and education. Discuss the primary safety issues associated with the major classes of oral agents used in managing type 2 diabetes. CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™
Diabetes Self Management: Barriers and Solutions David Kendall, M.D., Neil Skolnik, M.D., Laura Shane McWhorter, Pharm.D., C.D.E., et al Identify the agents and classes of agents that have the most evidence of efficacy with respect to hard outcomes in patients with diabetes. Counsel patients about the potential benefits and dangers associated with taking dietary supplements. Apply lessons from the Diabetes Prevention Program when counseling patients about lifestyle interventions and behavioral change. Implement practices to improve adherence with medical and lifestyle interventions. Help patients develop strategies to change their environments in ways that will foster healthier choices about eating. CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™
Possible Additional Course Available
If you have taken the current course listed here or if you need additional Diabetes credits, please call 800-446-5599 and ask about new courses in stock that are not listed on the website.
Here is what our clients are saying about American Seminar Institute's CME seminars...
"I was very impressed, as always, with my diabetes seminar. This is a perfect way for me to earn continuing education credits with the fexibility of program, location and schedule!" Jaquie,MD,Tampa, Florida
"..being able to schedule my continuing education around the demands of my family and in such a beautiful location was perfect. I'll tell my friends about you!" Sherry L.,PA,Chicago,
